Understanding Coagulation
Course Objectives
- Explain how hemostasis relates to coagulation testing and bleeding control after venipuncture.
- Apply collection and handling practices that protect coagulation specimen integrity.
- Recognize bleeding risks and specimen concerns that require additional precautions or communication with the healthcare team.
Course Content
Course Creator: Jayne Vanderstelt
Total CE Hours: 1 Credit Hour
Pace Course #: 586-3004-26
Outline:
I. Hemostasis in Practice
- Brief review of the vessel response, platelet plug formation, fibrin formation, clot stabilization, and fibrinolysis.
- Knowledge application: Assessing the puncture site when a patient says their platelet count is normal.
II. Understanding Coagulation Tests
- What common and specialized tests evaluate, including PT/INR, aPTT, thrombin time, platelet count, D-dimer, fibrin degradation products, and von Willebrand testing.
- Platelet clumping and recollection. Differences between factor V activity and Factor V Leiden testing.
- Knowledge application: Clarifying an order labeled only Factor V before collecting.
III.Protecting Coagulation Specimen Integrity
- Order verification, sodium citrate tube fill, order of draw, and winged collection devices.
- Special collection considerations for elevated hematocrit and vascular access devices.
- Specimen mixing, initial assessment, processing, transport, and recollection.
- Knowledge applications: Responding to a delayed courier and managing an underfilled citrate tube for an urgent PT/INR.
IV. Bleeding and Clotting Concerns in Practice
- Relevant patient history, medication use, collection precautions, and bleeding control after venipuncture.
- Collection and testing considerations for platelet disorders, hemophilia, von Willebrand disease, anticoagulant therapy, and selected clotting disorders.
- Knowledge application: Handling separate orders for PT/INR and protein C and protein S testing in a patient taking warfarin.
V. Key Takeaways
- Verify the order and collection requirements.
- Protect the specimen from collection through transport.
- Confirm bleeding control and communicate unresolved concerns.
References:
- Streiff, M. B. (2025, September). Overview of hemostasis. Merck Manual Professional Edition. https://www.merckmanuals.com/professional/hematology/hemostasis/overview-of-hemostasis
- World Health Organization. (2010). WHO guidelines on drawing blood: Best practices in phlebotomy. https://www.who.int/publications/i/item/9789241599221
- Labcorp. (n.d.). Blood specimens: Coagulation. Retrieved November 3, 2026, from https://www.labcorp.com/test-menu/resources/blood-specimens-coagulation
- National Heart, Lung, and Blood Institute. (2022, March 24). Platelet disorders: What are platelet disorders?https://www.nhlbi.nih.gov/health/platelet-disorders
- Mayo Clinic Laboratories. (n.d.). D-dimer, plasma (DDITT). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/40936
- Mayo Clinic Laboratories. (n.d.). Activated partial thromboplastin time, plasma (APTTP). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/40935
- Labcorp. (n.d.). Partial thromboplastin time (PTT), activated (005207). Retrieved November 3, 2026, from https://www.labcorp.com/tests/005207/partial-thromboplastin-time-ptt-activated
- Mayo Clinic Laboratories. (n.d.). Complete blood cell count (CBC) with differential, blood. Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/overview/9109
- Labcorp. (n.d.). Platelet count (005249). Retrieved November 3, 2026, from https://www.labcorp.com/tests/005249/platelet-count
- Mayo Clinic Laboratories. (n.d.). Coagulation factor V activity assay, plasma (FACTV). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/9054
- Mayo Clinic Laboratories. (n.d.). Factor V Leiden (R506Q) mutation, blood (F5DNA). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/81419
- Labcorp. (n.d.). Fibrinogen degradation products (FDP), plasma (115402). Retrieved November 3, 2026, from https://www.labcorp.com/tests/115402/fibrinogen-degradation-products-fdp-plasma
- Mayo Clinic Laboratories. (n.d.). Prothrombin time, plasma (PTTP). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/40934
- Mayo Clinic Laboratories. (n.d.). Thrombin time (bovine), plasma (TTSC). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/overview/602184
- Mayo Clinic Laboratories. (n.d.). von Willebrand disease profile, plasma (AVWPR). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/603550
- National Heart, Lung, and Blood Institute. (2023, March 24). Bleeding disorders: Diagnosis. https://www.nhlbi.nih.gov/health/bleeding-disorders/diagnosis
- National Heart, Lung, and Blood Institute. (2022, March 24). Platelet disorders: Thrombocythemia and thrombocytosis. https://www.nhlbi.nih.gov/health/thrombocythemia-thrombocytosis
- Mayo Clinic Laboratories. (n.d.). Lupus anticoagulant profile, plasma (ALUPP). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/603463
- National Heart, Lung, and Blood Institute. (2022, March 24). Blood clotting disorders: Disseminated intravascular coagulation (DIC). https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
- Mayo Clinic Laboratories. (n.d.). Thrombophilia profile, plasma and whole blood (AATHR). Retrieved November 3, 2026, from https://www.mayocliniclabs.com/test-catalog/overview/603304
